As acknowledged in the limitation section and noted by the reviewer, the rarity of these tumors and the small number of patients in most series, including ours, limits analysis. Hence, we did not aim to generalize our outcome. Our focus was on how the use of these modern tools can facilitate maximum safe tumor removal which is considered a pivotal factor in the management of chordoma and chondrosarcoma.
However, chordoma is a rare disease and reports on large patient series are rare.